⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL133148 | 0.88 | — | — | |
| SCHEMBL4906702 | 0.82 | — | — | |
| SCHEMBL8824145 | 0.82 | — | — | |
| SCHEMBL31463991 | 0.82 | — | — | |
| SCHEMBL22489 | 0.78 | — | — | |
| SCHEMBL10713958 | 0.78 | TSHR (0.46) | — | |
| SCHEMBL1264187 | 0.78 | — | — | |
| SCHEMBL4873099 | 0.78 | TSHR (0.46) | — | |
| SCHEMBL4438485 | 0.78 | — | — | |
| SCHEMBL18918455 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260015618-A1 | Therapeutic Compounds for Red Blood Cell-Mediated Delivery of an Active Pharmaceutical Ingredient to a Target Cell | K2B THERAPEUTICS INC (US) | 2026-01-15 | — | — | US | claimed |
| WO-2025110052-A1 | FABRIC LAMINATE STRUCTURE AND WATERPROOF/BREATHABLE GARMENT | 東レ株式会社 | 2025-05-30 | — | — | WO | claimed |
| US-20240317643-A1 | CEMENT BASED TILE ADHESIVE DRY MIX COMPOSITIONS CONTAINING CROSSLINKED CELLULOSE ETHERS FOR MORTARS WITH ENHANCED GEL STRENGTH | DOW GLOBAL TECHNOLOGIES LLC | 2024-09-26 | — | — | US | claimed |
| US-20240139148-A1 | COMPOSITIONS AND METHODS FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2024-05-02 | — | — | US | claimed |
| US-20230192549-A1 | CEMENTITIOUS SKIM COAT COMPOSITIONS CONTAINING CROSSLINKED CELLULOSE ETHERS FOR MORTARS WITH ENHANCED GEL STRENGTH | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-06-22 | — | — | US | claimed |
| WO-2022261459-A1 | COMPOSITIONS AND METHODS FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2022-12-15 | — | — | WO | claimed |
| CN-111205251-B | Preparation method of chiral ligand (3S,4S) -2, 5-dioxy tetrahydrofuran-3, 4-bis-carbamic acid benzyl ester | 苏州楚凯药业有限公司 | 2022-04-15 | — | — | CN | claimed |
| EP-3976190-A1 | NEW ENDOPEROXIDE COMPOUNDS, PROCESS FOR OBTAINING THEM AND USES THEREOF FOR CONTROL OF PERKINSIOSIS IN BIVALVES | CCMAR - Centro de Ciências Do Mar Universidade Do Algarve (PT) | 2022-04-06 | — | — | EP | claimed |
| CN-111205251-A | Preparation method of chiral ligand (3S,4S) -2, 5-dioxy tetrahydrofuran-3, 4-bis-carbamic acid benzyl ester | 苏州楚凯药业有限公司 | 2020-05-29 | — | — | CN | claimed |
| US-20090317408-A1 | LIGAND CONJUGATED THERMOTHERAPY SUSCEPTORS AND METHODS FOR PREPARING SAME | ADURO BIOTECH (US) | 2009-12-24 | — | — | US | claimed |
| US-6025335-A | L-DEOXYRIBOFURANOSYL NUCLEOSIDE PHOSPHODIESTER DIMERS WHERE THE SUGAR MOIETY OR AT LEAST ONE OF THE NUCLEOSIDES HAS AN L-CONFIGURATION, CANCER AND VIRAL INFECTIONS, IN MAMMALS. | LIPITEK INTERNATIONAL, INC. (US) | 2000-02-15 | — | — | US | claimed |
| WO-1999045935-A1 | NOVEL NUCLEOSIDE ANALOGS AND USES IN TREATING DISEASE | LIPITEK INTERNATIONAL, INC. (US) | 1999-09-16 | — | — | WO | claimed |
| US-5939402-A | TREATING PLASMODIUM, VIRAL INFECTIONS OR PARASITES IN MAMMALS | LIPITEK INTERNATIONAL, INC. (US) | 1999-08-17 | — | — | US | claimed |
| US-5876570-A | AZEOTROPIC DISTILLATION, GLYCOL ETHER HYDROPHILIC SOLVENT | HOECHST CELANESE CORPORATION (US) | 1999-03-02 | — | — | US | claimed |
| EP-0793669-A4 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | LIPITEK INTERNATIONAL INC (US) | 1999-02-03 | — | — | EP | claimed |
| EP-0793669-A1 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | Lipitek International, Inc. (US) | 1997-09-10 | — | — | EP | claimed |
| WO-1997011087-A1 | L-NUCLEOSIDE DIMER COMPOUNDS AND THERAPEUTIC USES | LIPITEK INTERNATIONAL, INC. (US) | 1997-03-27 | — | — | WO | claimed |
| EP-0125112-B1 | IMPROVED PROCESS FOR ANNEALING POLYESTER FILAMENTS AND NEW PRODUCTS THEREOF | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-01-03 | — | — | EP | claimed |
| US-4704329-A | STEAM, IMPROVED DYEABILITY, SHRINKAGE TENSILE STRENGTH | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-03 | — | — | US | claimed |
| EP-0125112-A2 | Improved process for annealing polyester filaments and new products thereof | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1984-11-14 | — | — | EP | claimed |